Genetics And Molecular Biology: A Literature Review Of Forensic Dentistry Application

Forensic expertise methodology normally used in different criminal investigation and forensic medicine field such as blood type, anthropologic analysis and forensic, dentistry (dental records, X-rays, bite marks, among others) solved and will continue solving many crimes. Those methods will continue estimating age of several people. Nevertheless, since the development of genetics and molecular bioloy there were an increase in number and quality of solved case. The present work points out the importance to associate certain forensic biology areas to traditional investigation methods in human identification, especially with forensic dentistry. It also show that in some situations, teeth are an important source to genetic analysis and molecular studies. After a scientific literature review it was concluded that it is mandatory that those in forensic investigations acquire knowledge in forensic genetics in order to apply with traditional investigation techniques, this fact would produce an increase of information to Justice.62012541259Ramos, D.I.A., Daruge, E., Daruge Júnior, E., Antunes, F.C.M., Melendez, B.V.C., Francesquini Júnior, L., Transposición dental y sus implicaciones eticas y legais (2005) Rev ADM, 62, pp. 185-190Gonçalves, A.C.S., Travassos, D.V., Silva, M., Campo de atuação do odontolegista (1999) RPG Rev Pos-Grad, 6, pp. 60-65Figini, A.R.L., Silva, J.R.L., Jobim, L.F., Silva, M., Tratado de perícias criminalísticas - identificação humana (2003) Campinas: Millenium Editora, , 2.edSilva, R.F., Cruz, B.V.M., Daruge Júnior, E., Daruge, E., Francesquini Júnior, L., La importância de la documentación odontológica en la identificación humana (2005) Acta Odontol Venez, 43, pp. 67-74Jeffreys, A.J., Wilson, V., Thein, S.L., Hypervariable minisatellite regions in human DNA (1985) Nature, 314, pp. 67-73Alonso, L.G., Genofre, G.C., Genética molecular e odontologia forense (1999) Rev Odontol Univ St Amaro, 4, pp. 30-33Homo Brasilis, P.S.D.J., Aspectos genéticos, lingüísticos, históricos e sócio-antropológicos da formação do povo brasileiro (2002) Ribeirão Preto: Editora FunpecSmith, B.C., Introduction to DNA analysis (2001) Dent Clin North Am, 45, pp. 229-235Jobim, L.F., Costa, L.R.S., Silva, M., Tratado de perícias criminalísticas - identificação humana (2006) Campinas: Millenium Editora, 2Edwards A, Civitello A, Hammond HA, Caskey CT. DNA Typing and Genetic Mapping with Trimeric and Tetrameric Tandem Repeats. Am J Hum Genet. 199149: 746-56Shriver, M.D., Mei, R., Parra, E.J., Sonpar, V., Halder, J., Tishkoff, A.S., Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variation (2005) Hum Genomics, 2, pp. 81-89Slavkin, H.C., Sex, enamel and forensic dentistry: A search for identity (1997) J Am Dent Assoc, 128, pp. 1021-1025Santos, M.C.L.G., Line, S.R.P., The epigenetics of enamel formation (2006) Braz J Oral Sci, 17, pp. 991-995Meyer, E., Wiese, M., Bruchhaus, H., Claussen, M., Klein, A., Extraction and amplification of authentic DNA from ancient human remains (2000) Forensic Sci Int, 113, pp. 87-90Faerman, M., Filon, D., Kahila, G., Greenblatt, C.L., Smith, P., Oppenheim, A., Sex identification of archaeological human remains based on amplification of the X and Y amelogenin alleles (1995) Gene, 167, pp. 327-332Liversidge, H.M., Lyons, F., Hector, M.P., The accuracy of three methods of age estimation using radiographic measurements of developing teeth (2003) Forensic Sci Int, 131, pp. 22-29Mesotten, K., Gunst, K., Carbonez, A., Willems, G., (2003) J Forensic Odontostomatol, 21, pp. 31-35Gustafson, G., Dental identification (1966) Forensic odontology, , London: Staples Press;Yamamoto, K., Molecular biological studies on teeth, and inquests (1996) Forensic Sci Int, 80, pp. 79-87Othani, S., Estimation of age from dentin by utilizing the racernization of aspartic acid: Influence of pH (1995) Forensic Sci Int, 75, pp. 181-187Ohtani, S., Yamada, Y., Yamamoto, I., Age estimation from racemization rate using heated teeth (1997) J Forensic Odontostomatol, 15, pp. 9-12Arany, S., Ohtani, S., Yoshioka, N., Gonmori, K., Age estimation from aspartic acid racemization of root dentin by internal standard method (2004) Forensic Sci Int, 141, pp. 127-130Sajdok, J., Pilin, A., Pudil, F., Zidková, J., Kás, J., A new method of age estimation based on the changes in human non-collagenous proteins from dentin (2006) Forensic Sci Int, 156, pp. 245-249Martín-de las Heras, S., Valenzuela, A., Overall, C.M., Gelatinase A in human dentin as a new biochemical marker for age estimation (2000) J Forensic Sci, 45, pp. 807-811Trevilatto, P.C., Line, S.R.P., Use of buccal epithelial cells for PCR amplification of large DNA fragments (2000) J Forensic Odontostomatol, 18, pp. 6-9Iwamura, E.S.M., Soares-Vieira, J.A., Muñoz, D.R., Human identification and analysis of DNA in bones (2004) Rev Hosp Clin Fac Med Sao Paulo, 59, pp. 383-388Andelinovic, S., Sutlovic, D., Ivkosic, I.E., Skaro, V., Ivkosic, A., Paic, F., Twelve-year experience in-identification of skeletal remains from mass graves (2005) Croat Med J, 46, pp. 530-539Lleonart, R., Riego, E., Suárez, R.R., Ruiz, R.T., Fuente, J., Analyses of DNA from ancient bones of a pre-columbian Cuban woman and a child (1999) Genet Mol Biol, 22, pp. 285-289Vernesi, C., Benedetto, G., Caramelli, D., Secchieri, E., Simoni, L., Katti, E., Genetic characterization of the body attributed to the evangelist Luke (2001) Proc Natl Acad Sci, 98, pp. 13460-13463Melki, J.A.D., Martin, C.C.S., Simões, A.L., Procedimentos em exumações para investigação de vínculo genético em ossos (2001) J Public Health, 35, pp. 368-374Ogata, M., Mattern, R., Schneider, P.M., Schacker, U., Kaufmann, T., Rittner, C., Quantitative and qualitative analysis of DNA extracted from postmortem muscle tissues (1990) Z Rechtsmed, 103, pp. 397-406Wurmb-Schwark, N., Harbeck, M., Wiesbrock, U., Schroeder, I., Ritz-Timme, S., Oehmichen, M., Extraction and amplification of nuclear and mitochondrial DNA from ancient and artificially aged bones (2003) Leg Med, 5, pp. S169-S172Bender, K., Farfán, M.J., Schneider, P.M., Preparation of degraded human DNA under controlled conditions (2004) Forensic Sci Int, 139, pp. 135-140Pretty, I.A., Sweet, D., A look at forensic dentistry. Part I: The role of teeth in the determination of human identity (2001) Br Dent J, 190, pp. 359-366Gaytmenn, R., Sweet, D., Quantification of forensic DNA from various regions of human teeth (2003) J Forensic Sci, 48, pp. 622-625Malaver, P.C., Yunis, J.J., Different dental tissues as source of DNA for human identification in forensic cases (2003) Croat Med J, 44, pp. 306-309Pfeiffer, H., Hühne, J., Seitz, B., Brinkmann, B., Influence of soil storage and exposure period on DNA recovery from teeth (1999) Int J Legal Med, 112, pp. 142-144Lessig, R., Edelmann, J., Individualisation of dental tissue - an aid for odontological identification? (1995) J Forensic Odontostomatol, 13, pp. 1-3Murakami, H., Yamamoto, Y., Yoshitome, K., Ono, T., Okamoto, O., Shigeta, Y., Forensic study of sex determination using PCR on teeth samples (2000) Acta Med Okayama, 54, pp. 21-32Sweet, D., Hildebrand, D., Redovery of DNA from human teeth by cryogenic grinding (1998) J Forensic Sci, 43, pp. 1199-1202Trivedi, R., Chattopadhyay, P., Kaghyap, K., A new improved method for extraction of DNA from teeth for the analysis of hypervariavel loci (2002) Am J Forensic Med Pathol, 23, pp. 191-196Kemp, B.M., Smith, D.G., Use of bleach to eliminate contaminating DNA from the surface of bones and teeths (2005) Forensic Sci Int, 154, pp. 53-61Schulz, M.M., Reichert, W., Archived or directly swabbed latent fingerprints as a DNA source for STR typing (2002) Forensic Sci Int, 127, pp. 128-130Goes, A.C.S., Silva, D.A., Domingues, C.S., Sobrinho, J.M., Carvalho, E.F., Identification of a criminal by DNA typing in a rape case in Rio de Janeiro, Brazil (2002) Sao Paulo Med J, 120, pp. 77-80Silva, D.A., Goes, A.C.S., Carvalho, J.J., Carvalho, E.F., DNA typing from vaginal smear slides in suspected rape cases (2004) Sao Paulo Med J, 122, pp. 70-72Silva, R.F., Pereira, S.D.R., Daruge Júnior, E., Daruge, E., Francesquini Júnior, L., A confiabilidade do exame odontolegal na identificação humana (2004) ROBRAC, 35, pp. 46-50Atsü SS, Gökdemir K, Kedici PS, Ikyaz YY. Bitemarks in forensic odontology. J Forensic Odontostomatol. 1998.16: 30-4McKenna CJ, Haron MI, Brown KA, Jones DAJ. Bitemarks in chocolate: a case report. J Forensic Odontostomatol. 200018: 10-4Sweet, D., Lorente, M., Lorente, J.A., Valenzuela, A., Villanueva, E., An improved method to recover saliva from human skin: The double swab technique (1997) J Forensic Sci, 42, pp. 320-322Bowers, C.M., (2004) Forensic dental evidence - An investigator's handbook, , San Diego: Elsevier;Borgula, L.M., Robinson, F.G., Rahimi, M., Chew, K.E., Birchmeier, K.R., Owens, S.Q., Isolation and genotypic comparison of oral streptococci from experimental bitemarks (2003) J Forensic Odontostomatol, 21, pp. 23-30Bilge, Y., Kedici, P.S., Alakoç, Y.D., Ûlküer, K., Ilkyaz, Y.Y., The identification of a dismembered human body: A multidisciplinary approach (2003) Forensic Sci Int, 137, pp. 141-146Sweet, D., Hidelbrand, D., Phillips, D., Identification of a skeleton using DNA from teeth and PAP smear (1999) J Forensic Sci, 44, pp. 630-633Soares-Vieira, J.A., Billerbeck, A.E.C., Iwamura, E.S.M., Cardoso, L.A., Muñoz, D.R., Post-mortem forensic identity testing: Application of PCR to the identification of fire victim (2000) Sao Paulo Med J, 118, pp. 75-77Sweet, D., Sweet, C.H.W., DNA analysis of dental pulp to link incinerated remains of homicide victim to crime scene (1995) J Forensic Sci, 40, pp. 310-314Yamada, Y., Ohira, H., Iwase, H., Takatori, T., Nagao, M., Ohtani, S., Sequencing mitochondrial DNA from a tooth and application to forensic odontology (1997) J Forensic Odontostmatol, 15, pp. 13-1

Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

Background: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019. Methods: 8078 country-years of vital registration and sample registration data, 938 surveys, 349 censuses, and 238 other sources were identified and used to estimate age-specific fertility. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate age-specific fertility rates for 5-year age groups between ages 15 and 49 years. With extensions to age groups 10–14 and 50–54 years, the total fertility rate (TFR) was then aggregated using the estimated age-specific fertility between ages 10 and 54 years. 7417 sources were used for under-5 mortality estimation and 7355 for adult mortality. ST-GPR was used to synthesise data sources after correction for known biases. Adult mortality was measured as the probability of death between ages 15 and 60 years based on vital registration, sample registration, and sibling histories, and was also estimated using ST-GPR. HIV-free life tables were then estimated using estimates of under-5 and adult mortality rates using a relational model life table system created for GBD, which closely tracks observed age-specific mortality rates from complete vital registration when available. Independent estimates of HIV-specific mortality generated by an epidemiological analysis of HIV prevalence surveys and antenatal clinic serosurveillance and other sources were incorporated into the estimates in countries with large epidemics. Annual and single-year age estimates of net migration and population for each country and territory were generated using a Bayesian hierarchical cohort component model that analysed estimated age-specific fertility and mortality rates along with 1250 censuses and 747 population registry years. We classified location-years into seven categories on the basis of the natural rate of increase in population (calculated by subtracting the crude death rate from the crude birth rate) and the net migration rate. We computed healthy life expectancy (HALE) using years lived with disability (YLDs) per capita, life tables, and standard demographic methods. Uncertainty was propagated throughout the demographic estimation process, including fertility, mortality, and population, with 1000 draw-level estimates produced for each metric. Findings: The global TFR decreased from 2•72 (95% uncertainty interval [UI] 2•66–2•79) in 2000 to 2•31 (2•17–2•46) in 2019. Global annual livebirths increased from 134•5 million (131•5–137•8) in 2000 to a peak of 139•6 million (133•0–146•9) in 2016. Global livebirths then declined to 135•3 million (127•2–144•1) in 2019. Of the 204 countries and territories included in this study, in 2019, 102 had a TFR lower than 2•1, which is considered a good approximation of replacement-level fertility. All countries in sub-Saharan Africa had TFRs above replacement level in 2019 and accounted for 27•1% (95% UI 26•4–27•8) of global livebirths. Global life expectancy at birth increased from 67•2 years (95% UI 66•8–67•6) in 2000 to 73•5 years (72•8–74•3) in 2019. The total number of deaths increased from 50•7 million (49•5–51•9) in 2000 to 56•5 million (53•7–59•2) in 2019. Under-5 deaths declined from 9•6 million (9•1–10•3) in 2000 to 5•0 million (4•3–6•0) in 2019. Global population increased by 25•7%, from 6•2 billion (6•0–6•3) in 2000 to 7•7 billion (7•5–8•0) in 2019. In 2019, 34 countries had negative natural rates of increase; in 17 of these, the population declined because immigration was not sufficient to counteract the negative rate of decline. Globally, HALE increased from 58•6 years (56•1–60•8) in 2000 to 63•5 years (60•8–66•1) in 2019. HALE increased in 202 of 204 countries and territories between 2000 and 2019. Interpretation: Over the past 20 years, fertility rates have been dropping steadily and life expectancy has been increasing, with few exceptions. Much of this change follows historical patterns linking social and economic determinants, such as those captured by the GBD Socio-demographic Index, with demographic outcomes. More recently, several countries have experienced a combination of low fertility and stagnating improvement in mortality rates, pushing more populations into the late stages of the demographic transition. Tracking demographic change and the emergence of new patterns will be essential for global health monitoring. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

Global burden of 87 risk factors in 204 countries and territories, 1990�2019: a systematic analysis for the Global Burden of Disease Study 2019

Background: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attributable burden of disease. Methods: GBD 2019 estimated attributable mortality, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 87 risk factors and combinations of risk factors, at the global level, regionally, and for 204 countries and territories. GBD uses a hierarchical list of risk factors so that specific risk factors (eg, sodium intake), and related aggregates (eg, diet quality), are both evaluated. This method has six analytical steps. (1) We included 560 risk�outcome pairs that met criteria for convincing or probable evidence on the basis of research studies. 12 risk�outcome pairs included in GBD 2017 no longer met inclusion criteria and 47 risk�outcome pairs for risks already included in GBD 2017 were added based on new evidence. (2) Relative risks were estimated as a function of exposure based on published systematic reviews, 81 systematic reviews done for GBD 2019, and meta-regression. (3) Levels of exposure in each age-sex-location-year included in the study were estimated based on all available data sources using spatiotemporal Gaussian process regression, DisMod-MR 2.1, a Bayesian meta-regression method, or alternative methods. (4) We determined, from published trials or cohort studies, the level of exposure associated with minimum risk, called the theoretical minimum risk exposure level. (5) Attributable deaths, YLLs, YLDs, and DALYs were computed by multiplying population attributable fractions (PAFs) by the relevant outcome quantity for each age-sex-location-year. (6) PAFs and attributable burden for combinations of risk factors were estimated taking into account mediation of different risk factors through other risk factors. Across all six analytical steps, 30 652 distinct data sources were used in the analysis. Uncertainty in each step of the analysis was propagated into the final estimates of attributable burden. Exposure levels for dichotomous, polytomous, and continuous risk factors were summarised with use of the summary exposure value to facilitate comparisons over time, across location, and across risks. Because the entire time series from 1990 to 2019 has been re-estimated with use of consistent data and methods, these results supersede previously published GBD estimates of attributable burden. Findings: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure. Global declines also occurred for tobacco smoking and lead exposure. The largest increases in risk exposure were for ambient particulate matter pollution, drug use, high fasting plasma glucose, and high body-mass index. In 2019, the leading Level 2 risk factor globally for attributable deaths was high systolic blood pressure, which accounted for 10·8 million (95 uncertainty interval UI 9·51�12·1) deaths (19·2% 16·9�21·3 of all deaths in 2019), followed by tobacco (smoked, second-hand, and chewing), which accounted for 8·71 million (8·12�9·31) deaths (15·4% 14·6�16·2 of all deaths in 2019). The leading Level 2 risk factor for attributable DALYs globally in 2019 was child and maternal malnutrition, which largely affects health in the youngest age groups and accounted for 295 million (253�350) DALYs (11·6% 10·3�13·1 of all global DALYs that year). The risk factor burden varied considerably in 2019 between age groups and locations. Among children aged 0�9 years, the three leading detailed risk factors for attributable DALYs were all related to malnutrition. Iron deficiency was the leading risk factor for those aged 10�24 years, alcohol use for those aged 25�49 years, and high systolic blood pressure for those aged 50�74 years and 75 years and older. Interpretation: Overall, the record for reducing exposure to harmful risks over the past three decades is poor. Success with reducing smoking and lead exposure through regulatory policy might point the way for a stronger role for public policy on other risks in addition to continued efforts to provide information on risk factor harm to the general public. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

Background Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 findings for all-cause mortality and cause-specific mortality in children younger than 5 years of age, with multiple scenarios for child mortality in 2030 that include the consideration of potential effects of COVID-19, and a novel framework for quantifying optimal child survival. Methods We completed all-cause mortality and cause-specific mortality analyses from 204 countries and territories for detailed age groups separately, with aggregated mortality probabilities per 1000 livebirths computed for neonatal mortality rate (NMR) and under-5 mortality rate (U5MR). Scenarios for 2030 represent different potential trajectories, notably including potential effects of the COVID-19 pandemic and the potential impact of improvements preferentially targeting neonatal survival. Optimal child survival metrics were developed by age, sex, and cause of death across all GBD location-years. The first metric is a global optimum and is based on the lowest observed mortality, and the second is a survival potential frontier that is based on stochastic frontier analysis of observed mortality and Healthcare Access and Quality Index. Findings Global U5MR decreased from 71·2 deaths per 1000 livebirths (95% uncertainty interval [UI] 68·3–74·0) in 2000 to 37·1 (33·2–41·7) in 2019 while global NMR correspondingly declined more slowly from 28·0 deaths per 1000 live births (26·8–29·5) in 2000 to 17·9 (16·3–19·8) in 2019. In 2019, 136 (67%) of 204 countries had a U5MR at or below the SDG 3.2 threshold and 133 (65%) had an NMR at or below the SDG 3.2 threshold, and the reference scenario suggests that by 2030, 154 (75%) of all countries could meet the U5MR targets, and 139 (68%) could meet the NMR targets. Deaths of children younger than 5 years totalled 9·65 million (95% UI 9·05–10·30) in 2000 and 5·05 million (4·27–6·02) in 2019, with the neonatal fraction of these deaths increasing from 39% (3·76 million [95% UI 3·53–4·02]) in 2000 to 48% (2·42 million; 2·06–2·86) in 2019. NMR and U5MR were generally higher in males than in females, although there was no statistically significant difference at the global level. Neonatal disorders remained the leading cause of death in children younger than 5 years in 2019, followed by lower respiratory infections, diarrhoeal diseases, congenital birth defects, and malaria. The global optimum analysis suggests NMR could be reduced to as low as 0·80 (95% UI 0·71–0·86) deaths per 1000 livebirths and U5MR to 1·44 (95% UI 1·27–1·58) deaths per 1000 livebirths, and in 2019, there were as many as 1·87 million (95% UI 1·35–2·58; 37% [95% UI 32–43]) of 5·05 million more deaths of children younger than 5 years than the survival potential frontier. Interpretation Global child mortality declined by almost half between 2000 and 2019, but progress remains slower in neonates and 65 (32%) of 204 countries, mostly in sub-Saharan Africa and south Asia, are not on track to meet either SDG 3.2 target by 2030. Focused improvements in perinatal and newborn care, continued and expanded delivery of essential interventions such as vaccination and infection prevention, an enhanced focus on equity, continued focus on poverty reduction and education, and investment in strengthening health systems across the development spectrum have the potential to substantially improve U5MR. Given the widespread effects of COVID-19, considerable effort will be required to maintain and accelerate progress

Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950�2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

Background: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019. Methods: 8078 country-years of vital registration and sample registration data, 938 surveys, 349 censuses, and 238 other sources were identified and used to estimate age-specific fertility. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate age-specific fertility rates for 5-year age groups between ages 15 and 49 years. With extensions to age groups 10�14 and 50�54 years, the total fertility rate (TFR) was then aggregated using the estimated age-specific fertility between ages 10 and 54 years. 7417 sources were used for under-5 mortality estimation and 7355 for adult mortality. ST-GPR was used to synthesise data sources after correction for known biases. Adult mortality was measured as the probability of death between ages 15 and 60 years based on vital registration, sample registration, and sibling histories, and was also estimated using ST-GPR. HIV-free life tables were then estimated using estimates of under-5 and adult mortality rates using a relational model life table system created for GBD, which closely tracks observed age-specific mortality rates from complete vital registration when available. Independent estimates of HIV-specific mortality generated by an epidemiological analysis of HIV prevalence surveys and antenatal clinic serosurveillance and other sources were incorporated into the estimates in countries with large epidemics. Annual and single-year age estimates of net migration and population for each country and territory were generated using a Bayesian hierarchical cohort component model that analysed estimated age-specific fertility and mortality rates along with 1250 censuses and 747 population registry years. We classified location-years into seven categories on the basis of the natural rate of increase in population (calculated by subtracting the crude death rate from the crude birth rate) and the net migration rate. We computed healthy life expectancy (HALE) using years lived with disability (YLDs) per capita, life tables, and standard demographic methods. Uncertainty was propagated throughout the demographic estimation process, including fertility, mortality, and population, with 1000 draw-level estimates produced for each metric. Findings: The global TFR decreased from 2·72 (95 uncertainty interval UI 2·66�2·79) in 2000 to 2·31 (2·17�2·46) in 2019. Global annual livebirths increased from 134·5 million (131·5�137·8) in 2000 to a peak of 139·6 million (133·0�146·9) in 2016. Global livebirths then declined to 135·3 million (127·2�144·1) in 2019. Of the 204 countries and territories included in this study, in 2019, 102 had a TFR lower than 2·1, which is considered a good approximation of replacement-level fertility. All countries in sub-Saharan Africa had TFRs above replacement level in 2019 and accounted for 27·1% (95% UI 26·4�27·8) of global livebirths. Global life expectancy at birth increased from 67·2 years (95% UI 66·8�67·6) in 2000 to 73·5 years (72·8�74·3) in 2019. The total number of deaths increased from 50·7 million (49·5�51·9) in 2000 to 56·5 million (53·7�59·2) in 2019. Under-5 deaths declined from 9·6 million (9·1�10·3) in 2000 to 5·0 million (4·3�6·0) in 2019. Global population increased by 25·7%, from 6·2 billion (6·0�6·3) in 2000 to 7·7 billion (7·5�8·0) in 2019. In 2019, 34 countries had negative natural rates of increase; in 17 of these, the population declined because immigration was not sufficient to counteract the negative rate of decline. Globally, HALE increased from 58·6 years (56·1�60·8) in 2000 to 63·5 years (60·8�66·1) in 2019. HALE increased in 202 of 204 countries and territories between 2000 and 2019. Interpretation: Over the past 20 years, fertility rates have been dropping steadily and life expectancy has been increasing, with few exceptions. Much of this change follows historical patterns linking social and economic determinants, such as those captured by the GBD Socio-demographic Index, with demographic outcomes. More recently, several countries have experienced a combination of low fertility and stagnating improvement in mortality rates, pushing more populations into the late stages of the demographic transition. Tracking demographic change and the emergence of new patterns will be essential for global health monitoring. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

Background Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 findings for all-cause mortality and cause-specific mortality in children younger than 5 years of age, with multiple scenarios for child mortality in 2030 that include the consideration of potential effects of COVID-19, and a novel framework for quantifying optimal child survival. Methods We completed all-cause mortality and cause-specific mortality analyses from 204 countries and territories for detailed age groups separately, with aggregated mortality probabilities per 1000 livebirths computed for neonatal mortality rate (NMR) and under-5 mortality rate (USMR). Scenarios for 2030 represent different potential trajectories, notably including potential effects of the COVID-19 pandemic and the potential impact of improvements preferentially targeting neonatal survival. Optimal child survival metrics were developed by age, sex, and cause of death across all GBD location-years. The first metric is a global optimum and is based on the lowest observed mortality, and the second is a survival potential frontier that is based on stochastic frontier analysis of observed mortality and Healthcare Access and Quality Index. Findings Global U5MR decreased from 71.2 deaths per 1000 livebirths (95% uncertainty interval WI] 68.3-74-0) in 2000 to 37.1 (33.2-41.7) in 2019 while global NMR correspondingly declined more slowly from 28.0 deaths per 1000 live births (26.8-29-5) in 2000 to 17.9 (16.3-19-8) in 2019. In 2019,136 (67%) of 204 countries had a USMR at or below the SDG 3.2 threshold and 133 (65%) had an NMR at or below the SDG 3.2 threshold, and the reference scenario suggests that by 2030,154 (75%) of all countries could meet the U5MR targets, and 139 (68%) could meet the NMR targets. Deaths of children younger than 5 years totalled 9.65 million (95% UI 9.05-10.30) in 2000 and 5.05 million (4.27-6.02) in 2019, with the neonatal fraction of these deaths increasing from 39% (3.76 million [95% UI 3.53-4.021) in 2000 to 48% (2.42 million; 2.06-2.86) in 2019. NMR and U5MR were generally higher in males than in females, although there was no statistically significant difference at the global level. Neonatal disorders remained the leading cause of death in children younger than 5 years in 2019, followed by lower respiratory infections, diarrhoeal diseases, congenital birth defects, and malaria. The global optimum analysis suggests NMR could be reduced to as low as 0.80 (95% UI 0.71-0.86) deaths per 1000 livebirths and U5MR to 1.44 (95% UI 1-27-1.58) deaths per 1000 livebirths, and in 2019, there were as many as 1.87 million (95% UI 1-35-2.58; 37% [95% UI 32-43]) of 5.05 million more deaths of children younger than 5 years than the survival potential frontier. Interpretation Global child mortality declined by almost half between 2000 and 2019, but progress remains slower in neonates and 65 (32%) of 204 countries, mostly in sub-Saharan Africa and south Asia, are not on track to meet either SDG 3.2 target by 2030. Focused improvements in perinatal and newborn care, continued and expanded delivery of essential interventions such as vaccination and infection prevention, an enhanced focus on equity, continued focus on poverty reduction and education, and investment in strengthening health systems across the development spectrum have the potential to substantially improve USMR. Given the widespread effects of COVID-19, considerable effort will be required to maintain and accelerate progress. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd

Five insights from the Global Burden of Disease Study 2019

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD 2019 incorporates data from 281 586 sources and provides more than 3·5 billion estimates of health outcome and health system measures of interest for global, national, and subnational policy dialogue. All GBD estimates are publicly available and adhere to the Guidelines on Accurate and Transparent Health Estimate Reporting. From this vast amount of information, five key insights that are important for health, social, and economic development strategies have been distilled. These insights are subject to the many limitations outlined in each of the component GBD capstone papers. © 2020 Elsevier Lt

Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

Background: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019. Methods: 8078 country-years of vital registration and sample registration data, 938 surveys, 349 censuses, and 238 other sources were identified and used to estimate age-specific fertility. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate age-specific fertility rates for 5-year age groups between ages 15 and 49 years. With extensions to age groups 10–14 and 50–54 years, the total fertility rate (TFR) was then aggregated using the estimated age-specific fertility between ages 10 and 54 years. 7417 sources were used for under-5 mortality estimation and 7355 for adult mortality. ST-GPR was used to synthesise data sources after correction for known biases. Adult mortality was measured as the probability of death between ages 15 and 60 years based on vital registration, sample registration, and sibling histories, and was also estimated using ST-GPR. HIV-free life tables were then estimated using estimates of under-5 and adult mortality rates using a relational model life table system created for GBD, which closely tracks observed age-specific mortality rates from complete vital registration when available. Independent estimates of HIV-specific mortality generated by an epidemiological analysis of HIV prevalence surveys and antenatal clinic serosurveillance and other sources were incorporated into the estimates in countries with large epidemics. Annual and single-year age estimates of net migration and population for each country and territory were generated using a Bayesian hierarchical cohort component model that analysed estimated age-specific fertility and mortality rates along with 1250 censuses and 747 population registry years. We classified location-years into seven categories on the basis of the natural rate of increase in population (calculated by subtracting the crude death rate from the crude birth rate) and the net migration rate. We computed healthy life expectancy (HALE) using years lived with disability (YLDs) per capita, life tables, and standard demographic methods. Uncertainty was propagated throughout the demographic estimation process, including fertility, mortality, and population, with 1000 draw-level estimates produced for each metric. Findings: The global TFR decreased from 2·72 (95% uncertainty interval [UI] 2·66–2·79) in 2000 to 2·31 (2·17–2·46) in 2019. Global annual livebirths increased from 134·5 million (131·5–137·8) in 2000 to a peak of 139·6 million (133·0–146·9) in 2016. Global livebirths then declined to 135·3 million (127·2–144·1) in 2019. Of the 204 countries and territories included in this study, in 2019, 102 had a TFR lower than 2·1, which is considered a good approximation of replacement-level fertility. All countries in sub-Saharan Africa had TFRs above replacement level in 2019 and accounted for 27·1% (95% UI 26·4–27·8) of global livebirths. Global life expectancy at birth increased from 67·2 years (95% UI 66·8–67·6) in 2000 to 73·5 years (72·8–74·3) in 2019. The total number of deaths increased from 50·7 million (49·5–51·9) in 2000 to 56·5 million (53·7–59·2) in 2019. Under-5 deaths declined from 9·6 million (9·1–10·3) in 2000 to 5·0 million (4·3–6·0) in 2019. Global population increased by 25·7%, from 6·2 billion (6·0–6·3) in 2000 to 7·7 billion (7·5–8·0) in 2019. In 2019, 34 countries had negative natural rates of increase; in 17 of these, the population declined because immigration was not sufficient to counteract the negative rate of decline

Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

Background In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990-2010 time period, with the greatest annualised rate of decline occurring in the 0-9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10-24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10-24 years were also in the top ten in the 25-49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50-74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI